Back

Parameters for better stratifying intermediate-high risk patients affected by acute pulmonary embolism

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk stratification and prognostication in acute cardiac care Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Claudia Colombo

ASST Great Metropolitan Niguarda, Milan (Italy)

4 More presentations in this session

Presentation thumbnail
Predictors of mortality in patients with cardiogenic shock and veno-arterial extracorporeal membrane oxygenation
Associate Professor M. Laimoud (Riyadh, SA)
Abstract Slides Video
Presentation thumbnail
Impact of chronic kidney disease on clinical outcomes after cardiac surgery
Associate Professor M. Laimoud (Riyadh, SA)
Abstract Slides Video
Presentation thumbnail
Simplified acute physiology score ii to predict hospital mortality among ST-elevation myocardial infarction patients in Switzerland
Ms L. Berther (St. Gallen, CH)
Abstract Slides Video
Presentation thumbnail
Complete revascularization strategy in patients with cardiogenic shock due to acute myocardial infarction: insights from the REGALIAM registry
Mr A. Gonzalez Garcia (Vigo, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification and prognostication in acute cardiac care

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Routine use of ultrasound-assisted catheter-directed thrombolysis for the management of intermediate-high risk pulmonary embolism: a service evaluation project
thumbnail
Congress Presentation
Risk assessment in patients with intermediate to high-risk pulmonary embolism: can the validated scores help predict the necessity of reperfusion therapy?
thumbnail
Congress Presentation
Standard-dose tPA vs. slow-infusion tPA vs. catheter-guided low-dose tPA in the treatment of patients with intermediate-high-risk pulmonary embolism

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources